BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2025.
World J Gastrointest Oncol. Dec 15, 2025; 17(12): 112873
Published online Dec 15, 2025. doi: 10.4251/wjgo.v17.i12.112873
Table 1 Patients’ characteristics, n (%)
Characteristics
Patients (n = 212)
Gender
    Male200 (94.3)
    Female12 (5.7)
Age (mean ± SD; range)58.8 ± 8.9 (34-80)
Height (cm), mean ± SD166.0 ± 6.5
Weight (kg), mean ± SD61.7 ± 11.3
BMI (kg/m2), mean ± SD22.3 ± 3.6
Histological subtype
    Adenocarcinoma7 (3.3)
    Squamous cell carcinoma205 (96.7)
T stage
    T111 (5.2)
    T27 (3.3)
    T3178 (84.0)
    T416 (7.5)
N stage
    N015 (7.1)
    N163 (29.7)
    N282 (38.7)
    N352 (24.5)
M stage
    M0182 (86.3)
    M129 (13.7)
ECOG
    025 (11.8)
    1169 (79.7)
    ≥ 28 (3.8)
    NA10 (4.7)
CT follow-up date from first CCRT (days), mean ± SD105.4 ± 38.0
Surgery treatment95 (44.8)
Surgery date from first CCRT (days), mean ± SD96.5 ± 82.3
Survival rate
    1-year149 (70.3)
    2-year101 (47.6)
    3-year82 (38.7)


Write to the Help Desk